Compared with an objective biomarker of drug-level measurements, self-report provides an accurate indicator for assessing preexposure prophylaxis use among New York City sexually transmitted infection clinic patients. Abstract In New… Click to show full abstract
Compared with an objective biomarker of drug-level measurements, self-report provides an accurate indicator for assessing preexposure prophylaxis use among New York City sexually transmitted infection clinic patients. Abstract In New York City, 91% of sexually transmitted infection clinic patients reported preexposure prophylaxis (PrEP) use that matched the detection of PrEP in their serum. Self-report had 80% sensitivity and 96% specificity (κ = 0.79) compared with measured PrEP. Our findings suggest that self-report may be a valid indicator of PrEP uptake.
               
Click one of the above tabs to view related content.